OXFORDphysics, Oxford, Oxon
Imperial College of Science and Technology, Department of Physics, London
UMAN, Manchester
STFC/DL/ASTeC, Daresbury, Warrington, Cheshire
Brunel University, Middlesex
STFC/RAL/ISIS, Chilton, Didcot, Oxon
STFC/RAL/ASTeC, Chilton, Didcot, Oxon
JAI, Oxford
Cockcroft Institute, Lancaster University, Lancaster
Manchester University, Manchester
Gray Cancer Institute, Northwood, Middlesex
Funding: EP/E032869/1
AMELA (Particle Accelerator for MEdicaL Applications) is a newly developed fixed field accelerator, which has capability for rapid beam acceleration, which is interesting for practical applications such as charged particle therapy. PAMELA aims to design a particle therapy facility using Non-Scaling FFAG technology, with a target beam repetition rate of 1kHz, which is far beyond that of conventional synchrotron. To realize the repetition rate, the key component is rf acceleration system. The combination of a high field gradient and a high duty factor is a significant challenge. In this paper, options for the system and the status of their development are presented.
Imperial College of Science and Technology, Department of Physics, London
BNL, Upton, Long Island, New York
STFC/RAL/ASTeC, Chilton, Didcot, Oxon
STFC/RAL, Chilton, Didcot, Oxon
Non-scaling FFAG rings have been proposed as a solution for muon acceleration in the Neutrino Factory. In order to achieve small orbit excursion and small time of flight variation, lattices with a very compact cell structure and short straight sections are required. The resulting geometry dictates very difficult constraints on injection/extraction systems. The feasibility of injection/extraction is discussed and various implementations focusing on minimization of kicker/septum strength are presented.
Brunel University, Middlesex
STFC/RAL, Chilton, Didcot, Oxon
STFC/RAL/ASTeC, Chilton, Didcot, Oxon
JAI, Oxford
The PAMELA project to design an accelerator for hadron therapy using non-scaling Fixed Field Alternating Gradient (NS-FFAG) magnets requires a transport line and gantry to take the beam to the patient. The NS-FFAG principle offers the possibility of a gantry much smaller, lighter and cheaper than conventional designs, with the added ability to accept a wide range of fast changing energies. This paper will build on previous work to investigate a transport line which could be used for the PAMELA project. The design is presented along with a study and optimisation of its acceptance.
JAI, Oxford
STFC/RAL/ASTeC, Chilton, Didcot, Oxon
PAMELA (Particle Accelerator for MEdicaL Applications) is a design for a non-scaling Fixed Field Alternating Gradient accelerator facility for Charged Particle Therapy, using protons and light ions such as carbon to treat certain types of cancer. A lattice has been designed which constrains the variation of betatron tunes through acceleration and thus avoids integer resonance crossing and beam blow-up. This paper outlines the design and performance of this proposed PAMELA lattice.
JAI, Oxford
Imperial College of Science and Technology, Department of Physics, London
UMAN, Manchester
STFC/DL/ASTeC, Daresbury, Warrington, Cheshire
STFC/DL, Daresbury, Warrington, Cheshire
STFC/RAL, Chilton, Didcot, Oxon
Brunel University, Middlesex
GIROB, Oxford
Fermilab, Batavia
Gray Institute for Radiation Oncology and Biology, Oxford
STFC/RAL/ASTeC, Chilton, Didcot, Oxon
Cockcroft Institute, Lancaster University, Lancaster
Funding: EPSRC EP/E032869/1
The PAMELA (Particle Accelerator for MEdicaL Applications) project is to design an accelerator for proton and light ion therapy using non-scaling Fixed Field Alternating Gradient (FFAG) accelerators, as part of the CONFORM project, which is also constructing the EMMA electron model of a non-scaling FFAG at Daresbury. This paper presents an overview of the PAMELA design, and a discussion of the design goals and the principles used to arrive at a preliminary specification of the accelerator.
